This text of Iowa § 124.551 (Information program for drug prescribing and dispensing) is published on Counsel Stack Legal Research, covering Iowa primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
1.Contingent upon the receipt of funds pursuant to section 124.557 sufficient to carry
out the purposes of this subchapter, the board, in conjunction with the advisory committee
created in section 124.555, shall establish and maintain an information program for drug
prescribing and dispensing.
2.
a.The program shall collect from pharmacies dispensing information for controlled
substances identified pursuant to section 124.554, subsection 1, paragraph “g”, and
from first responders as defined in section 147A.1, subsection 7, with the exception of
emergency medical care providers as defined in section 147A.1, subsection 4, administration
information for opioid antagonists. The department of health and human services shall
provide information for the administration of opioid antagonists to
Free access — add to your briefcase to read the full text and ask questions with AI
1. Contingent upon the receipt of funds pursuant to section 124.557 sufficient to carry
out the purposes of this subchapter, the board, in conjunction with the advisory committee
created in section 124.555, shall establish and maintain an information program for drug
prescribing and dispensing.
2. a. The program shall collect from pharmacies dispensing information for controlled
substances identified pursuant to section 124.554, subsection 1, paragraph “g”, and
from first responders as defined in section 147A.1, subsection 7, with the exception of
emergency medical care providers as defined in section 147A.1, subsection 4, administration
information for opioid antagonists. The department of health and human services shall
provide information for the administration of opioid antagonists to the board as prescribed
by rule for emergency medical care providers as defined in section 147A.1, subsection 4.
The board shall adopt rules requiring the following information to be provided regarding
the administration of opioid antagonists:
(1) Patient identification.
(2) Identification of the person administering opioid antagonists.
(3) The date of administration.
(4) The quantity of opioid antagonists administered.
b. The information collected shall be used by prescribing practitioners, veterinarians,
and pharmacists on a need-to-know basis for purposes of improving patient health care by
facilitating early identification of patients who may be at risk for addiction, or who may be
using, abusing, or diverting drugs for unlawful or otherwise unauthorized purposes at risk
to themselves and others, or who may be appropriately using controlled substances lawfully
prescribed for them but unknown to the practitioner.
3. The board shall implement technological improvements to facilitate secure access
to the program through electronic health and pharmacy information systems. The board
shall collect, store, and disseminate program information consistent with security criteria
established by rule, including use of appropriate encryption or other industry-recognized
security technology.
4. The board shall seek any federal waiver necessary to implement the provisions of the
program.